Capivasertib companion diagnostic - Foundation Medicine
Alternative Names: AZD-5363 companion diagnostic - Foundation Medicine; Truqap™ companion diagnostic - Foundation MedicineLatest Information Update: 18 Sep 2024
At a glance
- Originator Foundation Medicine
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed HER2 negative breast cancer
Most Recent Events
- 18 Sep 2024 Launched for HER2-negative-breast-cancer (Diagnosis) in Japan (unspecified route) before September 2024 (Foundation Medicine website, September 2024)
- 18 Sep 2024 Launched for HER2-negative-breast-cancer (Diagnosis) in USA (unspecified route) before September 2024 (Foundation Medicine website, September 2024)
- 26 Mar 2024 Registered for HER2-negative-breast-cancer (Diagnosis) in Japan (unspecified route)